International
A US and Italian review and re-analysis of existing studies on convalescent plasma treatment for COVID-19 found it may help prevent death among immunocompromised patients. The new research included eight controlled studies and 138 case studies, and found that transfusion of COVID-19 convalescent plasma was linked to a decrease in death risk in immunocompromised patients, compared with control groups who were not given the plasma treatment. These findings suggest that transfusion of COVID-19 convalescent plasma may help prevent death among immunocompromised patients whose condition does not respond to other treatments, the authors conclude.
From:
About The Study: The findings this systematic review and meta-analysis suggest that transfusion of COVID-19 convalescent plasma is associated with mortality benefit for patients who are immunocompromised and have COVID-19.
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Sign In
